Skip to main content

Advertisement

Log in

Spontaneous coronary thrombosis following thrombolytic therapy for acute cardiovascular accident and stroke: a case study

  • Published:
Journal of Thrombosis and Thrombolysis Aims and scope Submit manuscript

Abstract

Cardiac complications following stroke or acute cerebrovascular accidents (CVA) are common; however, many of these complications are asymptomatic and do not cause adverse cardiac effects. Symptomatic events (such as acute myocardial infarction after CVA) rarely occur and are often the result of an underlying cardiac embolic source, such as a left ventricular thrombus. We report a case of spontaneous coronary thrombosis following thrombolytic therapy for acute CVA, and discuss the implication that an underlying systemic pro-thrombotic state may predispose individuals to thrombosis in disparate vascular beds.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

References

  1. Chin PL, Kaminski J, Rout M (1977) Myocardial infarction coincident with cerebrovascular accidents in the elderly. Age Ageing 6:29–37

    Article  PubMed  CAS  Google Scholar 

  2. Johnston KC, Li JY, Lyden PD, Hanson SK, Feasby TE et al (1998) Medical and neurological complications of ischemic stroke: experience from the RANTTAS trial. RANTTAS investigators. Stroke 29:447–453

    Article  PubMed  CAS  Google Scholar 

  3. Chalela JA, Ezzeddine MA, Davis L, Warach S (2004) Myocardial injury in acute stroke: a troponin I study. Neurocrit Care 1:343–346

    Article  PubMed  Google Scholar 

  4. Sweta A, Sejal S, Prakash S, Vinay C, Shirish H (2010) Acute myocardial infarction following intravenous tissue plasminogen activator for acute ischemic stroke: an unknown danger. Ann Indian Acad Neurol 13:64–66

    Article  PubMed  Google Scholar 

  5. Mehdiratta M, Murphy C, Al-Harthi A, Teal PA (2007) Myocardial infarction following t-PA for acute stroke. Can J Neurol Sci 34:417–420

    PubMed  CAS  Google Scholar 

  6. Meissner W, Lempert T, Saeuberlich-Knigge S, Bocksch W, Pape UF (2006) Fatal embolic myocardial infarction after systemic thrombolysis for stroke. Cerebrovasc Dis 22:213–214

    Article  PubMed  Google Scholar 

  7. Adams HP Jr, del Zoppo G, Alberts MJ, Bhatt DL, Brass L et al (2007) Guidelines for the early management of adults with ischemic stroke: a guideline from the American heart association/American stroke association stroke council, clinical cardiology council, cardiovascular radiology and intervention council, and the atherosclerotic peripheral vascular disease and quality of care outcomes in research interdisciplinary working groups: the American academy of neurology affirms the value of this guideline as an educational tool for neurologists. Circulation 115:e478–e534

    Article  PubMed  Google Scholar 

  8. Sen S, Laowatana S, Lima J, Oppenheimer SM (2004) Risk factors for intracardiac thrombus in patients with recent ischaemic cerebrovascular events. J Neurol Neurosurg Psychiatry 75:1421–1425

    Article  PubMed  CAS  Google Scholar 

  9. Garg A, Yaduvanshi A, Mohindra KD (2010) Cardioembolic stroke on unaffected side during thrombolysis for acute ischemic stroke. Neurol India 58:112–114

    Article  PubMed  Google Scholar 

  10. Amarenco P, Steg PG (2008) Stroke is a coronary heart disease risk equivalent: implications for future clinical trials in secondary stroke prevention. Eur Heart J 29:1605–1607

    Article  PubMed  Google Scholar 

  11. Touze E, Varenne O, Chatellier G, Peyrard S, Rothwell PM et al (2005) Risk of myocardial infarction and vascular death after transient ischemic attack and ischemic stroke: a systematic review and meta-analysis. Stroke 36:2748–2755

    Article  PubMed  Google Scholar 

  12. Wysokinski WE, McBane RD 2nd, Owen WG (1999) Individual propensity for arterial thrombosis. Arterioscler Thromb Vasc Biol 19:883–886

    Article  PubMed  CAS  Google Scholar 

  13. Smyth SS, Monroe DM III, Wysokinski WE, McBane RD II, Whiteheart SW et al (2008) Platelet activation and its patient-specific consequences. Thromb Res 122:435–441

    Article  PubMed  CAS  Google Scholar 

  14. Antman EM, Anbe DT, Armstrong PW, Bates ER, Green LA et al (2004) ACC/AHA guidelines for the management of patients with ST-elevation myocardial infarction-executive summary. A report of the American college of cardiology/American heart association task force on practice guidelines (writing committee to revise the 1999 guidelines for the management of patients with acute myocardial infarction). J Am Coll Cardiol 44:671–719

    Article  PubMed  Google Scholar 

  15. Tanne D, Macko RF, Lin Y, Tilley BC, Levine SR (2006) Hemostatic activation and outcome after recombinant tissue plasminogen activator therapy for acute ischemic stroke. Stroke 37:1798–1804

    Article  PubMed  CAS  Google Scholar 

  16. Gulba DC, Barthels M, Westhoff-Bleck M, Jost S, Rafflenbeul W et al (1991) Increased thrombin levels during thrombolytic therapy in acute myocardial infarction. Relevance for the success of therapy. Circulation 83:937–944

    Article  PubMed  CAS  Google Scholar 

  17. Eisenberg PR, Sobel BE, Jaffe AS (1992) Activation of prothrombin accompanying thrombolysis with recombinant tissue-type plasminogen activator. J Am Coll Cardiol 19:1065–1069

    Article  PubMed  CAS  Google Scholar 

  18. Simoons M, Krzeminska-Pakula M, Alonso A, Goodman S, Kali A et al (2002) Improved reperfusion and clinical outcome with enoxaparin as an adjunct to streptokinase thrombolysis in acute myocardial infarction. The AMI–SK study. Eur Heart J 23:1282–1290

    Article  PubMed  CAS  Google Scholar 

  19. International Stroke Trial Collaborative Group (1997) The international stroke trial (IST): a randomised trial of aspirin, subcutaneous heparin, both, or neither among 19435 patients with acute ischaemic stroke. Lancet 349:1569–1581

    Article  Google Scholar 

  20. CAST (Chinese Acute Stroke Trial) Collaborative Group (1997) CAST: randomised placebo-controlled trial of early aspirin use in 20,000 patients with acute ischaemic stroke. Lancet 349:1641–1649

    Article  Google Scholar 

  21. Sandercock PA, Gibson LM, Liu M (2009) Anticoagulants for preventing recurrence following presumed non-cardioembolic ischaemic stroke or transient ischaemic attack. Cochrane Database Syst Rev 2:CD000248

  22. Seet RC, Zhang Y, Moore SA, Wijdicks EF, Rabinstein AA (2011) Subtherapeutic international normalized ratio in warfarin-treated patients increases the risk for symptomatic intracerebral hemorrhage after intravenous thrombolysis. Stroke 42:2333–2335

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

The authors wish to thank Susan Quick for outstanding editorial support. This work was supported by the National Center for Research Resources and the National Center for Advancing Translational Sciences, National Institutes of Health, through Grant 1UL1RR033173. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. This work was also supported by resources and/or the use of facilities at the Lexington VA Medical Center.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Eric L. Wallace.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wallace, E.L., Smyth, S.S. Spontaneous coronary thrombosis following thrombolytic therapy for acute cardiovascular accident and stroke: a case study. J Thromb Thrombolysis 34, 548–551 (2012). https://doi.org/10.1007/s11239-012-0754-2

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11239-012-0754-2

Keywords

Navigation